Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Viva Gold Reports Strong Initial Assay Results for its Fall 2024 Drill Program (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Science 37 Holdings Inc SNCE

Financial Services Technology Scientific & Technical Instruments
Science 37 Holdings, Inc. is engaged in patient-centric clinical trials and in supporting novel approaches to decentralized clinical trial designs. Through its patient-centric approach, it reduces the impact of the geographic barriers associated with conventional physical clinical trial sites, enabling recruitment of virtually any patient. Its offerings lie in its configurable unified... see more

Recent & Breaking News (NDAQ:SNCE)

Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire April 10, 2023

Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire March 10, 2023

Science 37 Reports Fourth Quarter and Full Year 2022 Financial Results

GlobeNewswire March 6, 2023

Science 37 to Present at the Cowen 43rd Annual Health Care Conference

GlobeNewswire February 23, 2023

Science 37 to Report Fourth Quarter 2022 Financial Results on March 6, 2023

GlobeNewswire February 21, 2023

Science 37 Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire February 10, 2023

Science 37 Acquires Vault Health's Life Sciences Platform To Bolster its Metasite Capabilities

GlobeNewswire February 2, 2023

Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire January 6, 2023

Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire December 9, 2022

Science 37 to Present at the 5ᵗʰ Annual Evercore ISI HealthCONx Conference

GlobeNewswire November 30, 2022

Science 37 and BEKHealth Collaborate to Expand Patient Access Via Community Providers

GlobeNewswire November 22, 2022

Science 37 and Linical Announce Partnership to Enable Fully Decentralized and Hybrid Trials

GlobeNewswire November 17, 2022

Science 37 Named Best in Class for Telehealth Innovation at UCSF Health Hub Digital Health Awards 2022

GlobeNewswire November 15, 2022

Science 37 Reports Third Quarter 2022 Financial Results

GlobeNewswire November 10, 2022

Science 37 to Report Third Quarter 2022 Financial Results on November 10, 2022

GlobeNewswire November 1, 2022

Science 37 appoints Paul von Autenried to its Board of Directors

GlobeNewswire October 5, 2022

Science 37 Names Industry Veteran Michael Shipton as Chief Commercial Officer

GlobeNewswire September 12, 2022

Science 37 to Present at the Baird 2022 Global Healthcare Conference

GlobeNewswire September 8, 2022

Science 37 and NuvoAir Partner to Bring Patient-Centric Experience to Respiratory Clinical Trials

GlobeNewswire September 7, 2022

New Science Technology Accelerates Patient Recruitment and Enrollment

GlobeNewswire August 24, 2022